MedPath

Effects of magnesium sulfate in prevention of shivering during spinal anesthesia in cesarean sectio

Phase 2
Conditions
Spinal anesthesia.
Other complications of spinal and epidural anesthesia during pregnancy
Registration Number
IRCT20160926029976N2
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Pregnant women
ASA I
spinal anesthesia
caesarean section

Exclusion Criteria

Fever before surgery(T>38)
Hypothermia(T<36.5)
evidence of elevated intracranial pressure
Allergy to case study drugs
Thyroid Disease
Parkinson
Raynaud's syndrome
Ischemic heart disease
cerebrovascular disorders
administration of Magnesium
administration of petedine
Hypertension
renal disease
history of use of cardiac drugs
Antihypertensive drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Temperature. Timepoint: Befor spinal anesthesia and every 15 minutes to 120 minutes during surgery. Method of measurement: Genius 2 Electronic Thermometer.;Blood pressure. Timepoint: Every 15 minutes to 120 minutes during surgery. Method of measurement: Non-invasive with Cuff.;Heart rate. Timepoint: Every 15 minutes to 120 minutes during surgery. Method of measurement: monitoring.;Nausea & Vomiting. Timepoint: Every 15 minutes to 120 minutes during surgery. Method of measurement: Observation and question.;Shiver. Timepoint: During opreation every 15 minutes to 120 minutes. Method of measurement: Rate of Crossely & Mahajan.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath